Search / Trial NCT00001156

Assessment of Patients With Multiple Sclerosis (MS)

Launched by NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE (NINDS) · Nov 3, 1999

Trial Information

Current as of December 27, 2024

Completed

Keywords

Immunogenetics Tropical Spastic Paraplegia Twins Epstein Barr Virus Htlv I Vasculitis Cerebrospinal Fluid Immunity To Viruses Multiple Sclerosis Magnetic Resonance Imaging

ClinConnect Summary

The Neuroimmunology Branch (NIB) conducts research into the cause of immunologically mediated diseases of the nervous system such as multiple sclerosis (MS). The studies in the NIB range for studies of the natural history of MS to trials of new experimental therapies. In order to recruit patients into the various NIB research studies, patients with a tentative diagnosis are initially seen by the NIB to assess the accuracy of the diagnosis and to assess the level of disease activity occurring in the patient. Patients seen under the NIB screening protocol are evaluated in clinic with a comple...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Diagnosis of possible MS.
  • Age between 18 and 75.
  • EXCLUSION CRITERIA:
  • Clinically significant medical condition other than MS that could cause neurological dysfunction.
  • Currently enrolled in an experimental study.
  • Medical contraindication for MRI.
  • Psychological contraindications for MRI.
  • Unable to provide informed consent.

About National Institute Of Neurological Disorders And Stroke (Ninds)

The National Institute of Neurological Disorders and Stroke (NINDS) is a leading component of the National Institutes of Health (NIH), dedicated to advancing our understanding of the brain and nervous system through innovative research. NINDS sponsors and conducts clinical trials aimed at developing effective treatments and improving patient outcomes for a wide range of neurological disorders, including stroke, epilepsy, multiple sclerosis, and neurodegenerative diseases. By fostering collaboration among researchers, healthcare providers, and patient communities, NINDS plays a pivotal role in transforming scientific discoveries into clinical applications, ultimately enhancing the quality of life for individuals affected by neurological conditions.

Locations

Bethesda, Maryland, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials